spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Tag: Biogen licenses Vanqua Bio's immune disorder drug for up to $1.06 billion

Biogen licenses Vanqua Bio’s immune disorder drug for up to $1.06 billion

Biogen said on Friday it has gained global rights to privately held Vanqua Bio's experimental drug for up to...